Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Atorvastatin on Frailty Syndrome Indicators in HIV Patients Receiving Antiretroviral Therapy
TCTR20240418003Phase 2Completed
- Sponsor
- Faculty of Medicine, Universitas Syiah Kuala
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in human immunodeficiency virus infection (HIV), Fragility, sponsored by Faculty of Medicine, Universitas Syiah Kuala. Started Jan 2024; status: completed.
02
Drugs
atorvastatin
03
Conditions
human immunodeficiency virus infection (HIV)Fragility
Beyond the preview
Go deeper on TCTR20240418003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240418003.